F.D.A. Panel Recommends M.S. Drug Despite Lethal Risk
Thu, 09 Mar 2006 03:00 AM EST
ANDREW POLLACK... The advisory panel said that patients and their physicians should be able to decide whether the considerable benefits of Tysabri outweigh its risks. ...
Related Topics
- Liver Panel
- Risk Factors
- Security Risk Assessment
- Cardiac Risk
- High Risk Pregnancy
- Drug Safety
- Prescription Drugs
- Youth Risk Behaviors
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- CVD
- Club Drugs
- Youth Risk Behavior Surveillance System
- Pregnancy and Substance Abuse
- Cutaneous Drug Reactions
- Electrolytes
- Urinalysis

Not Signed In -


